HR 3920 · 114th Congress 2015–2017, ended

E-Free Act

Introduced Nov 4, 2015 Originated House Sponsor Michael G. Fitzpatrick R-PA

Fact sheet Spreadsheet

Latest action · Dec 10, 2015 Sponsor introductory remarks on measure. (CR H9210)

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedNov 4, 2015
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

E-Free Act

This bill requires the Food and Drug Administration to withdraw approval for Essure, a medical device for permanent, non-surgical female sterilization.

Cosponsors 7

Members who signed on, in the order they did. Signatures ran from Nov 4, 2015 to Jun 14, 2016; 3 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-NJChristopher H. SmithOriginalNov 4, 2015
D-MPGregorio Kilili Camacho SablanOriginalNov 4, 2015
R-TNMarsha BlackburnOriginalNov 4, 2015
R-PALou BarlettaNov 18, 2015
R-OKTom ColeFeb 10, 2016
D-OHMarcy KapturApr 27, 2016
R-NCRobert PittengerJun 14, 2016

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Nov 4, 2015
Health Subcommittee
Referred Nov 6, 2015

Actions 4

Everything that happened, newest first.

  1. Dec 10, 2015Sponsor introductory remarks on measure. (CR H9210)
  2. Nov 6, 2015Referred to the Subcommittee on Health.
  3. Nov 4, 2015Introduced in House
  4. Nov 4, 2015Referred to the House Committee on Energy and Commerce.

In the Congressional Record 8

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H1035Michael G. Fitzpatrick R-PAFeb 29, 2016
HouseDebate and remarks H420Michael G. Fitzpatrick R-PAFeb 1, 2016
HouseDebate and remarks H291Michael G. Fitzpatrick R-PAJan 12, 2016
HouseDebate and remarks H7Michael G. Fitzpatrick R-PAJan 5, 2016
HouseDebate and remarks H9677Michael G. Fitzpatrick R-PADec 17, 2015
HouseDebate and remarks H9210Michael G. Fitzpatrick R-PADec 10, 2015
HouseDebate and remarks H9087Michael G. Fitzpatrick R-PADec 9, 2015
HouseDebate and remarks H7378Michael G. Fitzpatrick R-PANov 2, 2015

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 3

The sponsor’s statement, as printed in the Congressional Record, vol. 161, no. 164, November 4, 2015, page H7742.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To direct the Commissioner of Food and Drugs to issue an order withdrawing approval for Essure System.
Short Titles as Introduced
E-Free Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Nov 4, 2015Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.